[
    [
        {
            "time": "2021-06-15",
            "original_text": "Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters",
            "features": {
                "keywords": [
                    "Biogen",
                    "Aduhelm",
                    "slow rollout",
                    "price competition"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-15",
            "original_text": "Roche executive says Alzheimer's drug price will be competitive",
            "features": {
                "keywords": [
                    "Roche",
                    "Alzheimer's",
                    "drug price",
                    "competitive"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Roche executive says Alzheimer's drug price will be competitive",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-15",
            "original_text": "CORRECTED-Roche executive says Alzheimer's drug price will be competitive",
            "features": {
                "keywords": [
                    "Roche",
                    "Alzheimer's",
                    "drug price",
                    "competitive"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "CORRECTED-Roche executive says Alzheimer's drug price will be competitive",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]